Novo Nordisk A/S (NONOF)
OTCMKTS
· Delayed Price · Currency is USD
68.25
+1.77 (2.66%)
Jun 27, 2025, 3:59 PM EDT
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$567,426
Profits / Employee
$195,821
Market Cap
304.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
American Oncology Network | 1,914 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
Novo Nordisk News
- 18 hours ago - Spain Accuses Novo Nordisk Of Covert Advertising For Prescription Weight-Loss Drugs - Benzinga
- 20 hours ago - Health Rounds: Novo Nordisk's semaglutide may help some with type 1 diabetes - Reuters
- 23 hours ago - Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover? - The Motley Fool
- 23 hours ago - ‘Very obvious:’ Novo Nordisk may be illegally advertising Ozempic, says Spain’s health secretary - Euronews
- 1 day ago - Novo Nordisk says WeightWatchers will sell Wegovy, announces US$299 price - BNN Bloomberg
- 1 day ago - What's Going On With Hims & Hers Health Stock Today? - Benzinga
- 1 day ago - Novo Nordisk taps WeightWatchers for Wegovy after exiting Hims & Hers deal - Seeking Alpha
- 1 day ago - Novo Nordisk to Expand Access to Wegovy with WeightWatchers Partnership - WSJ